Skip to main content
SpringerLink
Log in

Nach kurativ intendierter Radiochemotherapie

Additive Chemotherapie verbessert das RFS von NPC-Patienten mit EBV-DNA-Last nicht

  • journal club
  • Published:
InFo Hämatologie + Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  1. Chan ATC et al. J Clin Oncol. 2018; https://doi.org/10.1200/JCO.2018.77.7847

    Google Scholar 

  2. Al-Sarraf M et al. J Clin Oncol. 1998;16(4):1310–7

    Article  CAS  Google Scholar 

  3. Lee N et al. Int J Radiat Oncol Biol Phys. 2002;53(1):12–22

    Article  Google Scholar 

  4. Chua MLK et al. Lancet. 2016;387(10022):1012–24

    Article  Google Scholar 

  5. Wee J. Lancet Oncol. 2012;13(2):116–8

    Article  Google Scholar 

  6. Zhang L et al. Lancet. 2016;388(10054):1883–92

    Article  CAS  Google Scholar 

  7. Chen L et al. Lancet Oncol. 2012;13(2):163–71

    Article  Google Scholar 

  8. Chen L et al. Eur J Cancer. 2017;75:150–8

    Article  CAS  Google Scholar 

  9. Lee AW et al. J Clin Oncol. 2015;33(29):3356–64

    Article  Google Scholar 

Literatur

  • Erstpubliziert in Strahlenther Onkol. 2019;195(1):90-1

Literatur

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik für Strahlentherapie, Medizinische Fakultät Otto-von-Guericke-Universität Magdeburg, Magdeburg, Deutschland

    Christoph Willich &  Thomas B. Brunner

Authors
  1. Christoph Willich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas B. Brunner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christoph Willich.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Willich, C., Brunner, T.B. Additive Chemotherapie verbessert das RFS von NPC-Patienten mit EBV-DNA-Last nicht. Info Onkol. 22, 33–34 (2019). https://doi.org/10.1007/s15004-019-6474-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-019-6474-4

Search

Navigation